An Experimental Study of Morphofunctional Features of Hair Follicles Early Response in Cyclophosphamide-Induced Alopecia

The aim of the study was to determine the effect of 3-β-methoxy-Δ18-oleanene (miliacin) on the structural and functional reorganization of hair follicles at the early response stage in the simulated cyclophosphamide-induced alopecia. Material and methods. The study involved 30 male C57BL/6 mice with the anagen stage induced by depilation of hair shafts from the skin of the back. The animals were divided into five groups: I and II – control groups, III, IV and V groups – experimental ones. The animals of group I were exposed to depilation only. The animals of group IV was daily exposed to topical skin applications of 3-β-methoxy-Δ18- oleanene (miliacin) diluted in polyoxyethylated (20) sorbitan oleate in the area of depilation. The animals of group V were only exposed to polyoxyethylated (20) sorbitan oleate. In 9 days after depilation, the animals of the experimental groups received a single injection of cyclophosphamide solution, dosage 125 mg/kg, intraperitoneally; the animals of the control group II received the same volume of 0.9% sodium chloride solution. All animals were withdrawn from the experiment on day 15. The skin of the back in the depilation zone was studied using light microscopy, morphometry and statistics. Results. In 15 days after anagen induction, all hair follicles were synchronized at the anagen VI stage in the skin of mice in the control groups. Exclusively dystrophic forms of hair follicles were detected in the skin of mice of groups III and V. In the skin of animals of group IV, hair follicles predominated in the early and middle anagen stages without signs of dystrophy; the portion of hair follicles in the late dystrophic catagen stage accounted for only 9.2±3.27% of the total number of hair follicles. Conclusion. Topical use of a composition with 3-β-methoxy-Δ18-oleanene (miliacin) leads to an accelerated transition of chemically damaged hair follicles from the anagen VI stage to the dystrophic catagen and a shortening of the telogen stage, which resulted in the entry of the overwhelming majority of hair follicles of mice in this group into the next new cycle of hair follicle development (anagen stages I, II, III).

1. Goryachkina V.L., Ivanova M.Yu., Tsomartova D.A., Kartashkina N.L., Kuznetsov S.L., et al. Modern Concepts on the Histophysiology of Hair Follicles. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2015; 18(3):51–4 (In Russ.).

2. Olifson L.E., Osadchaya N.D., Nuzov B.G., et al. Nature and Biological Activity of Miliacine. Problems of Nutrition. 1991;2:57–9 (In Russ.).

3. Boudon S., Kurka P., Gnacke C., et al. The patent Canada №EP-3453381-B1; 2017.

4. Dunnill C.J., Al-Tameemi W., Collett A., Haslam I.S., Georgopoulos N.T. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention. The Oncologist. 2017 Sep 26;23(1):84–96. doi: 10.1634/theoncologist.2017-0263

5. Hendrix S., Bori Handjiski, Eva M.J. Peters, Paus R. A Guide to Assessing Damage Response Pathways of the Hair Follicle: Lessons From Cyclophosphamide-Induced Alopecia in Mice. Journal of Investigative Dermatology. 2005 Jul 1;125(1):42–51. doi: 10.1111/j.0022-202X.2005.23787.x

6. Jadkauskaite L., Coulombe P.A., Schäfer M., Dinkova-Kostova A.T., Paus R., Haslam I.S. Oxidative stress management in the hair follicle: Could targeting NRF2 counter age-related hair disorders and beyond? BioEssays. 2017 Jul 7;39(8):1700029. doi: 10.1002/bies.201700029

7. Lamay F., Lamour I., Gaillard E. The patent № US- 9180135-B2; 2013.

8. Malkinson F.D., Keane J.A. Radiobiology of the Skin: Review of Some Effects on Epidermis and Hair. The Journal of investigative dermatology. 1981 Jul 1;77(1):133–8. doi: 10.1111/1523-1747.ep12479347

9. Paus R., Handjiski B., Eichmüller S., Czarnetzki B.M. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. PubMed. 1994 Apr 1;144(4):719–34.